Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Colorcon
McKesson
Moodys
Cerilliant
US Army
Healthtrust
Harvard Business School

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050754

« Back to Dashboard

NDA 050754 describes AMOXIL, which is a drug marketed by Dr Reddys Labs Inc and Glaxosmithkline and is included in eight NDAs. It is available from five suppliers. Additional details are available on the AMOXIL profile page.

The generic ingredient in AMOXIL is amoxicillin. There are forty-five drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 050754
Tradename:AMOXIL
Applicant:Dr Reddys Labs Inc
Ingredient:amoxicillin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050754
Ingredient-typePenicillins
Medical Subject Heading (MeSH) Categories for 050754
Suppliers and Packaging for NDA: 050754
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMOXIL amoxicillin TABLET;ORAL 050754 NDA Dr Reddys Laboratories Inc 43598-219 N 43598-219-01
AMOXIL amoxicillin TABLET;ORAL 050754 NDA Dr Reddys Laboratories Inc 43598-219 N 43598-219-14

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength875MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 10, 1998TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 10, 1998TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Colorcon
Merck
Federal Trade Commission
Covington
Cipla
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.